title: Colitis associated with biological agents.
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, 1 University of New Mexico, MSC10-5550, Albuquerque, NM, 87131, USA, kkhirfan@salud.unm.edu.
authors.forename: K
authors.initials: K
authors.lastname: Khirfan
authors.forename: M
authors.initials: M
authors.lastname: Kistin
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003092:Colitis / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D000074324:Ipilimumab; D008297:Male; D008875:Middle Aged; D013256:Steroids / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab; D013256:Steroids; D000069285:Infliximab
references.citation: Rheumatology (Oxford). 2009 Jul;48(7):761-4
references.pmid: 19395543
references.citation: J Clin Oncol. 2006 May 20;24(15):2283-9
references.pmid: 16710025
references.citation: J Immunother. 2005 Nov-Dec;28(6):593-8
references.pmid: 16224277
references.citation: Melanoma Res. 2013 Jun;23(3):227-30
references.pmid: 23458760
references.citation: Dig Dis Sci. 2009 Nov;54(11):2538-40
references.pmid: 19104936
references.citation: World J Gastroenterol. 2012 Apr 28;18(16):1871-4
references.pmid: 22563166
references.citation: J Clin Gastroenterol. 2013 Oct;47(9):781-5
references.pmid: 23632354
references.citation: J Clin Oncol. 2012 Jul 20;30(21):2691-7
references.pmid: 22614989
references.citation: Cancer Biother Radiopharm. 2009 Jun;24(3):321-5
references.pmid: 19538054